Integral Health Asset Management’s Penumbra PEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-100,000
Closed -$31.1M 106
2025
Q4
$31.1M Buy
100,000
+50,000
+100% +$13.8M 1.54% 19
2025
Q3
$12.7M Buy
50,000
+10,000
+25% +$2.52M 0.86% 37
2025
Q2
$10.3M Buy
40,000
+5,000
+14% +$1.36M 0.94% 33
2025
Q1
$9.36M Buy
+35,000
New +$9.47M 1% 29
2024
Q2
Sell
-70,000
Closed -$15.6M 96
2024
Q1
$15.6M Buy
70,000
+30,000
+75% +$7.42M 1.45% 25
2023
Q4
$10.1M Buy
+40,000
New +$8.84M 1.37% 30
2023
Q3
Sell
-30,000
Closed -$10.3M 84
2023
Q2
$10.3M Sell
30,000
-5,000
-14% -$1.54M 1.28% 33
2023
Q1
$9.75M Buy
35,000
+5,000
+17% +$1.28M 1.96% 20
2022
Q4
$6.67M Buy
+30,000
New +$5.87M 1.4% 29

Other funds holding PEN

Integral Health Asset Management's PEN Position: Q1 2026 in Review

Integral Health Asset Management sold out of Penumbra (PEN) in Q1 2026, closing a stake of 100,000 shares — an estimated $31.1M sold.

Integral Health Asset Management first reported a position in PEN in Q4 2022 and held it in 9 quarters. The position peaked at $31.1M in Q4 2025. 485 funds tracked by Wall St. Rank hold PEN as of Q1 2026.

  • Integral Health Asset Management reported no remaining Penumbra position as of Q1 2026 after selling out during the quarter.
  • Integral Health Asset Management sold 100,000 Penumbra shares in Q1 2026, an estimated $31.1M.
  • Integral Health Asset Management first reported a position in Penumbra in Q4 2022 and held it in 9 quarters.
  • Integral Health Asset Management's Penumbra position peaked at $31.1M in Q4 2025.
  • 485 funds tracked by Wall St. Rank held Penumbra as of Q1 2026.

Based on Integral Health Asset Management's 13F filing for Q1 2026, filed 15 May 2026.